These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38609999)

  • 1. Soluble CD27 is an intrathecal biomarker of T-cell-mediated lesion activity in multiple sclerosis.
    Cencioni MT; Magliozzi R; Palmisano I; Suwan K; Mensi A; Fuentes-Font L; Villar LM; Fernández-Velasco JI; Migallón NV; Costa-Frossard L; Monreal E; Ali R; Romozzi M; Mazarakis N; Reynolds R; Nicholas R; Muraro PA
    J Neuroinflammation; 2024 Apr; 21(1):91. PubMed ID: 38609999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid soluble CD27 is associated with CD8
    El Mahdaoui S; Husted SR; Hansen MB; Cobanovic S; Mahler MR; Buhelt S; von Essen MR; Sellebjerg F; Romme Christensen J
    J Neuroimmunol; 2023 Aug; 381():578128. PubMed ID: 37321014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis.
    Komori M; Blake A; Greenwood M; Lin YC; Kosa P; Ghazali D; Winokur P; Natrajan M; Wuest SC; Romm E; Panackal AA; Williamson PR; Wu T; Bielekova B
    Ann Neurol; 2015 Jul; 78(1):3-20. PubMed ID: 25808056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiplex assessment of cerebrospinal fluid biomarkers in multiple sclerosis.
    Mahler MR; Søndergaard HB; Buhelt S; von Essen MR; Romme Christensen J; Enevold C; Sellebjerg F
    Mult Scler Relat Disord; 2020 Oct; 45():102391. PubMed ID: 32679525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.
    Krumbholz M; Theil D; Cepok S; Hemmer B; Kivisäkk P; Ransohoff RM; Hofbauer M; Farina C; Derfuss T; Hartle C; Newcombe J; Hohlfeld R; Meinl E
    Brain; 2006 Jan; 129(Pt 1):200-11. PubMed ID: 16280350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions.
    Fransen NL; Hsiao CC; van der Poel M; Engelenburg HJ; Verdaasdonk K; Vincenten MCJ; Remmerswaal EBM; Kuhlmann T; Mason MRJ; Hamann J; Smolders J; Huitinga I
    Brain; 2020 Jun; 143(6):1714-1730. PubMed ID: 32400866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cells producing GM-CSF and IL-13 are enriched in the cerebrospinal fluid of relapsing MS patients.
    Ghezzi L; Cantoni C; Cignarella F; Bollman B; Cross AH; Salter A; Galimberti D; Cella M; Piccio L
    Mult Scler; 2020 Sep; 26(10):1172-1186. PubMed ID: 31237799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated levels of a soluble form of the T cell activation antigen CD27 in cerebrospinal fluid of multiple sclerosis patients.
    Hintzen RQ; van Lier RA; Kuijpers KC; Baars PA; Schaasberg W; Lucas CJ; Polman CH
    J Neuroimmunol; 1991 Dec; 35(1-3):211-7. PubMed ID: 1659587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine and immune cell profiling in the cerebrospinal fluid of patients with neuro-inflammatory diseases.
    Lepennetier G; Hracsko Z; Unger M; Van Griensven M; Grummel V; Krumbholz M; Berthele A; Hemmer B; Kowarik MC
    J Neuroinflammation; 2019 Nov; 16(1):219. PubMed ID: 31727097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid concentrations of soluble CD27 in HTLV-I associated myelopathy and multiple sclerosis.
    Hintzen RQ; Paty D; Oger J
    J Neurol Neurosurg Psychiatry; 1999 Jun; 66(6):791-3. PubMed ID: 10329758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of effector CD4 (OX-40+) and CD8 (CD45RA+CD27-) T lymphocytes in active multiple sclerosis.
    Hintzen RQ; Pot K; Paty D; Oger J
    Acta Neurol Scand; 2000 Jan; 101(1):57-60. PubMed ID: 10660154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Ependymal-in" Gradient of Thalamic Damage in Progressive Multiple Sclerosis.
    Magliozzi R; Fadda G; Brown RA; Bar-Or A; Howell OW; Hametner S; Marastoni D; Poli A; Nicholas R; Calabrese M; Monaco S; Reynolds R
    Ann Neurol; 2022 Oct; 92(4):670-685. PubMed ID: 35748636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-155 and functional proteins of CD8+ T cells as potential prognostic biomarkers for relapsing-remitting multiple sclerosis.
    Elkhodiry AA; Zamzam DA; El Tayebi HM
    Mult Scler Relat Disord; 2021 Aug; 53():103078. PubMed ID: 34171684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of membrane B7-H3 costimulatory molecule but reduction of its soluble form in multiple sclerosis.
    Jiang J; Jiang J; Liu C; Zhang G; Gao L; Chen Y; Zhu R; Wang T; Wang F; Zhang X; Xue Q
    J Clin Immunol; 2013 Jan; 33(1):118-26. PubMed ID: 22996270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue factor as a potential coagulative/vascular marker in relapsing-remitting multiple sclerosis.
    Koudriavtseva T; Lorenzano S; Cellerino M; Truglio M; Fiorelli M; Lapucci C; D'Agosto G; Conti L; Stefanile A; Zannino S; Filippi MM; Cortese A; Piantadosi C; Maschio M; Maialetti A; Galiè E; Salvetti M; Inglese M
    Front Immunol; 2023; 14():1226616. PubMed ID: 37583699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Retinal Architecture, Intrathecal Immunity, and Clinical Course in Multiple Sclerosis.
    Knier B; Leppenetier G; Wetzlmair C; Aly L; Hoshi MM; Pernpeintner V; Biberacher V; Berthele A; Mühlau M; Zimmer C; Hemmer B; Korn T
    JAMA Neurol; 2017 Jul; 74(7):847-856. PubMed ID: 28460032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells.
    Machado-Santos J; Saji E; Tröscher AR; Paunovic M; Liblau R; Gabriely G; Bien CG; Bauer J; Lassmann H
    Brain; 2018 Jul; 141(7):2066-2082. PubMed ID: 29873694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1 receptor antagonist: An exploratory plasma biomarker that correlates with disability and provides pathophysiological insights in relapsing-remitting multiple sclerosis.
    Blandford SN; Galloway DA; Williams JB; Arsenault S; Brown J; MacLean G; Moore GRW; Barron J; Ploughman M; Clift F; Stefanelli M; Moore CS
    Mult Scler Relat Disord; 2021 Jul; 52():103006. PubMed ID: 34004435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in systemic and central nervous system cellular immunity relevant to relapsing-remitting multiple sclerosis.
    Matsui M; Araya S; Wang HY; Matsushima K; Saida T
    J Neurol; 2005 Aug; 252(8):908-15. PubMed ID: 15772738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention.
    van Langelaar J; van der Vuurst de Vries RM; Janssen M; Wierenga-Wolf AF; Spilt IM; Siepman TA; Dankers W; Verjans GMGM; de Vries HE; Lubberts E; Hintzen RQ; van Luijn MM
    Brain; 2018 May; 141(5):1334-1349. PubMed ID: 29659729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.